The invention generally relates to solid forms of berberine ursodeoxycholate,and to pharmaceutical compositions, andmethods of preparation and therapeutic use thereof. In particular, theinvention relates to solid forms of berberine ursodeoxycholate andpharmaceutical compositions thereof useful in treating and/or preventingvarious diseases or disorders, including metabolic disorders,heart diseases, neurodegenerative diseases and liver diseases.